Insights from 2023 SABCS


 

SABCS 2023 Insights: "APHINITY Trial - The Benefit of Adjuvant Pertuzumab & Trastuzumab According to Estrogen Receptor and HER2 Expression"

293 views
December 13, 2023
Comments 0
Login to view comments. Click here to Login